Ian Craig Lawrance

Summary

Affiliation: University of Western Australia
Country: Australia

Publications

  1. ncbi request reprint Poor correlation between clinical impression, the small colonic polyp and their neoplastic risk
    Ian Craig Lawrance
    School of Medicine and Pharmacology, University of Western Australia, Western Australia, Australia
    J Gastroenterol Hepatol 21:563-8. 2006
  2. ncbi request reprint A comparative study of goblet cell and pancreatic exocine autoantibodies combined with ASCA and pANCA in Chinese and Caucasian patients with IBD
    Ian Craig Lawrance
    School of Medicine and Pharmacology, University of Western Australia
    Inflamm Bowel Dis 11:890-7. 2005
  3. ncbi request reprint Proteomics: an overview
    Ian Craig Lawrance
    School of Medicine and Pharmacology, University of Western Australia, Fremantle
    Inflamm Bowel Dis 11:927-36. 2005
  4. pmc Correlation of MRI-determined small bowel Crohn's disease categories with medical response and surgical pathology
    Ian Craig Lawrance
    School of Medicine and Pharmacology, University of Western Australia, Fremantle Hospital, Fremantle, WA 6160, Australia
    World J Gastroenterol 15:3367-75. 2009
  5. doi request reprint Modifying T-cell trafficking to the intestinal as a potential management for inflammatory bowel disease
    Ian Craig Lawrance
    University of Western Australia, Fremantle Hospital, Centre for inflammatory Bowel Diseases, WA and School of Medicine and Pharmacology, T Block, Alma Street, Fremantle, 6059 WA, Australia
    Expert Opin Investig Drugs 21:975-84. 2012
  6. ncbi request reprint A prospective comparative study of ASCA and pANCA in Chinese and Caucasian IBD patients
    Ian Craig Lawrance
    Department of Gastroenterology, University Department of Medicine and Pharmacology, University of Western Australia, Fremantle Hospital, WA, Australia
    Am J Gastroenterol 99:2186-94. 2004
  7. ncbi request reprint Indomethacin and retinoic acid modify mouse intestinal inflammation and fibrosis: a role for SPARC
    Borut Klopcic
    School of Medicine and Pharmacology, University of Western Australia, Fremantle, WA, Australia
    Dig Dis Sci 53:1553-63. 2008
  8. pmc Stevens-Johnson syndrome complicating adalimumab therapy in Crohn's disease
    Muna Salama
    Department of Medicine and Pharmacology, University of Western Australia, T Block, Fremantle Hospital, Fremantle 6059, WA, Australia
    World J Gastroenterol 15:4449-52. 2009

Collaborators

Detail Information

Publications8

  1. ncbi request reprint Poor correlation between clinical impression, the small colonic polyp and their neoplastic risk
    Ian Craig Lawrance
    School of Medicine and Pharmacology, University of Western Australia, Western Australia, Australia
    J Gastroenterol Hepatol 21:563-8. 2006
    ..Our aims were to determine if clinical discernment is accurate, and the likelihood that lesions < 10 mm are histologically advanced...
  2. ncbi request reprint A comparative study of goblet cell and pancreatic exocine autoantibodies combined with ASCA and pANCA in Chinese and Caucasian patients with IBD
    Ian Craig Lawrance
    School of Medicine and Pharmacology, University of Western Australia
    Inflamm Bowel Dis 11:890-7. 2005
    ..This study determined the sensitivity, specificity, and positive and negative predictive values (PPV and NPV) of PAB and GAB +/- ASCA and pANCA testing in Chinese and Caucasian IBD populations...
  3. ncbi request reprint Proteomics: an overview
    Ian Craig Lawrance
    School of Medicine and Pharmacology, University of Western Australia, Fremantle
    Inflamm Bowel Dis 11:927-36. 2005
  4. pmc Correlation of MRI-determined small bowel Crohn's disease categories with medical response and surgical pathology
    Ian Craig Lawrance
    School of Medicine and Pharmacology, University of Western Australia, Fremantle Hospital, Fremantle, WA 6160, Australia
    World J Gastroenterol 15:3367-75. 2009
    ..To determine whether magnetic resonance imaging (MRI) can be used to categorize small bowel Crohn's disease (SB CD) into groups that correlate with response to medical therapy and surgical pathology...
  5. doi request reprint Modifying T-cell trafficking to the intestinal as a potential management for inflammatory bowel disease
    Ian Craig Lawrance
    University of Western Australia, Fremantle Hospital, Centre for inflammatory Bowel Diseases, WA and School of Medicine and Pharmacology, T Block, Alma Street, Fremantle, 6059 WA, Australia
    Expert Opin Investig Drugs 21:975-84. 2012
    ..There is a desperate need for new therapies that target the immunological deficits within the immune system with low side effects and long-term efficacy...
  6. ncbi request reprint A prospective comparative study of ASCA and pANCA in Chinese and Caucasian IBD patients
    Ian Craig Lawrance
    Department of Gastroenterology, University Department of Medicine and Pharmacology, University of Western Australia, Fremantle Hospital, WA, Australia
    Am J Gastroenterol 99:2186-94. 2004
    ..Antisaccharomyces cerevisiae (ASCA) and antineutrophil cytoplasmic antibodies (pANCA) can aid in the differentiation between Crohn's disease (CD) and ulcerative colitis (UC), but their sensitivity may vary between races...
  7. ncbi request reprint Indomethacin and retinoic acid modify mouse intestinal inflammation and fibrosis: a role for SPARC
    Borut Klopcic
    School of Medicine and Pharmacology, University of Western Australia, Fremantle, WA, Australia
    Dig Dis Sci 53:1553-63. 2008
    ..The results demonstrate that indomethacin increases TNBS-induced fibrosis in mice, while RA reduces it, and that SPARC may link these opposing effects...
  8. pmc Stevens-Johnson syndrome complicating adalimumab therapy in Crohn's disease
    Muna Salama
    Department of Medicine and Pharmacology, University of Western Australia, T Block, Fremantle Hospital, Fremantle 6059, WA, Australia
    World J Gastroenterol 15:4449-52. 2009
    ..These reactions can be serious and prescribers need to be aware of the potential mucocutaneous side effects of these agents, especially as Stevens-Johnson syndrome is associated with significant morbidity and mortality...